David Wainer


Preston's Summary

David Wainer is a columnist for The Wall Street Journal and Yahoo Finance. He specializes in writing about the intersection of finance, healthcare, and biotechnology, providing insights into investment trends and market analysis. His work has also been featured in JD Supra.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus


Coverage Attributes:

Investment Analysis: 43 %
Cites Data: 32 %
Press Release: 10 %
Private Sector Announcements: 2 %
Government Announcement: 2 %

Themes Covered:

Most Recent Topics:

  • Pharmaceutical Industry
  • Drug Companies
  • Healthcare Innovation
  • Biotechnology
  • Medical Research

Pitching Insights

David Wainer's coverage predominantly focuses on investment analysis within the healthcare and pharmaceutical sectors. His articles encompass a range of topics, including stocks, biotech, and investing in relation to developments within these industries.

Given his focus on investment analysis and citation of data, David would likely be interested in receiving pitches from experts who can provide insightful perspectives backed by data related to healthcare and pharmaceutical companies' performance or industry trends. Additionally, professionals with expertise in financial analysis specific to the healthcare sector may find success when reaching out to him.

Considering his concentration on the international market rather than a specific geographic area, sources providing global insights into healthcare investments and pharmaceutical developments could capture his attention effectively.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Most recent topics
Healthcare & Pharmaceutical, Sales & Marketing, Scientific, Consumer Electronics, Biotechnology
Annika Kim Constantino
Senior Staff Reporter
Most recent topics
Healthcare & Pharmaceutical, Sales & Marketing, Government & Politics, Health & Wellbeing, Scientific
Most recent topics
Finance, Healthcare & Pharmaceutical, Health, Sales & Marketing, Business
Most recent topics
Government & Politics, Healthcare & Pharmaceutical, Politics, Entertainment, Weather
Most recent topics
Healthcare & Pharmaceutical, Health, Sales & Marketing, Finance, Tech
Angel Adegbesan
Business Reporter
Most recent topics
Healthcare & Pharmaceutical, Finance, Big Tech, Biotechnology, Health